SCHEMBL4348986

SCHEMBL4348986

CCN(CC)C1=NC(=O)/C(=C/c2ccc(Cl)cc2)S1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.56
KMT2A Q03164 3/20 0.56
NPC1 O15118 1/20 0.56
TNNI3 P19429 1/20 0.56
TNNT2 P45379 1/20 0.56
RAB9A P51151 1/20 0.56
GFER P55789 1/20 0.56
TNNC1 P63316 1/20 0.56
ALDH1A1 P00352 2/20 0.53
ENPP2 Q13822 1/20 0.53
MITF O75030 1/20 0.53
LMNA P02545 1/20 0.53
CYP1A2 P05177 1/20 0.53
CYP2C9 P11712 1/20 0.53
HPGD P15428 1/20 0.53
CYP2C19 P33261 1/20 0.53
POLB P06746 1/20 0.52
ALOX5 P09917 8/20 0.51
MYC P01106 1/20 0.46
MAX P61244 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4348992 1.00 MEN1 (0.56) MEN1KMT2ANPC1TNNI3TNNT2
Bromide SCHEMBL4357393 0.99 MEN1 (0.55) MEN1KMT2ANPC1TNNI3TNNT2
Bromide SCHEMBL4357396 0.99 MEN1 (0.55) MEN1KMT2ANPC1TNNI3TNNT2
SCHEMBL4348545 0.87 RAB9A (0.58) MEN1KMT2ANPC1TNNI3TNNT2
SCHEMBL4348541 0.87 RAB9A (0.58) MEN1KMT2ANPC1TNNI3TNNT2
Bromide SCHEMBL4348012 0.86 RAB9A (0.56) MEN1KMT2ANPC1TNNI3TNNT2
Bromide SCHEMBL4348013 0.86 RAB9A (0.56) MEN1KMT2ANPC1TNNI3TNNT2
SCHEMBL4350154 0.86 POLB (0.71) MEN1KMT2ANPC1TNNI3TNNT2
SCHEMBL4350157 0.86 POLB (0.71) MEN1KMT2ANPC1TNNI3TNNT2
SCHEMBL14589646 0.85 MEN1 (0.62) MEN1KMT2ANPC1TNNI3TNNT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1890695-B1 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS GRUENENTHAL GMBH (DE) 2013-02-20 EP claimed
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs GRUENENTHAL GMBH (DE) 2009-08-27 US claimed
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs GRUENENTHAL GMBH (DE) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs ABCB1, ABCG2, SLC5A2 MEN1 1725/4885KMT2A 3923/4885NPC1 326/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.